EVIDENT Initiative

EVIDENT Initiative is a grant from the Advanced Research Projects Agency for Health (ARPA-H) that funds research to transform behavioral health treatment by developing objective, FDA-ready clinical endpoints for rapid-acting therapies. With up to $139.

4 million available, EVIDENT supports work on digital interventions, neuromodulation, and neuroplastogens—including psychedelics—to build the measurement science needed for precise, personalized behavioral health care. At least $50 million is allocated to match state government investments in psychedelic research for populations with serious mental illness.

Eligible applicants include research institutions, universities, and organizations engaged in behavioral health clinical trials and data science. Awards are made on a rolling basis to teams addressing objective measurement, treatment response, and shared data infrastructure.

# ARPA-H announces first research teams for $139 million initiative to transform behavioral health and bring new, more precise and effective treatments to Americans | HHS. gov A **. gov** website belongs to an official government organization in the United States.

Join HHS in Celebrating Freedom 250 [](https://www. hhs. gov/ "Home") HHS is a U.S. executive department that touches the lives of nearly all Americans by protecting your rights, research, food safety, health care, aging, and much more.

* Opportunities for Attorneys * Join the Health Workforce * New Employee Orientation * Transportation Services * Standards and Compliance * Digital Communications Standards * Accountability and Transparency * Freedom of Information Act (FOIA) HHS is responsible for public health, health care, and human/social services for the United States of America. This includes administering over 100 programs and services.

Explore Programs & Services * Find an Indian Health Service Facility * Find Support for Mental Health, Drugs, or Alcohol * Medicare – 65+ or With Disability * Medicaid - Low-Income, With Disability, or Pregnant * Children’s Health Insurance Programs (CHIP) * Find Health Insurance Coverage * Insurance Help for Mental Health and Substance Use * No Surprise Medicals Bills * Programs for Children and Families * Programs for People with Disabilities * Programs for Older Adults * Resources for Caregivers * Public Health and Prevention * Emergency Preparedness and Response * Mental Health and Substance Use * Food Safety and Nutrition * Drug and Product Safety * Health Research and Information * National Library of Medicine * Surgeon General Reports * National Center for Health Statistics * Clinical Research Studies * Volunteering to Participate in Research HHS protects and helps you understand the laws and regulations, also known as "rules," that govern the nation.

You also have the power to voice your opinion on these laws and regulations.

Explore Laws & Regulations * Suggest Deregulatory Actions * Understand Key Federal Laws * Civil Rights Laws Enforced by HHS * Health Information Privacy * Substance Use Disorder Patient Confidentiality * Conscience and Religious Freedom * Laws and Regulations by Topic * Health Insurance Protections * Public Health Emergencies * Human Research Protections * Regulations, Policy, and Guidance * Human Subjects Regulations (45 CFR 46) * Register IRBs and Obtain FWAs * Trainings, Tutorials, and Workshops * File a Medicare Complaint * File a Civil Rights Complaint * Appeal an Insurance Company Decision * Report Fraud, Waste, and Abuse to OIG * Report a Problem to the FDA * Report a Tip on the Chemical and Surgical Mutilation of Children HHS gives the most money in grants of any federal agency in the U.S. Find out about our grants and how your organization can apply for them.

We also provide information on how you can work with us and our support of small businesses. Explore Grants & Contracts * Get Ready for Grants Management * Grant Policies and Regulations * Research Grants and Funding from NIH * Contact HHS Grant Officials * Get Ready to Do Business with HHS * Programs for Businesses * Contract Policies and Regulations * Search Opportunities on SAM.

gov * Contact HHS Contracting Managers * Small Business Programs * Small Business Resources * Contact Small Business Staff HHS protects and helps you understand the laws and regulations, also known as "rules," that govern the nation. You also have the power to voice your opinion on these laws and regulations.

Explore Radical Transparency * CDC’s ACIP Conflicts of Interest * Ending Anti-Semitism on College Campuses * Ending Wasteful Spending * Keeping Food Ingredients Safe * Chemical Contaminants Transparency Tool 3. ARPA-H announces first research teams for $139 million initiative to transform behavioral health and bring new, more precise and effective treatments to Americans * [](https://www. hhs.

gov/press-room/arpa-h-announces-research-teams-initiative-transform-behavioral-health. html "Print") * [](https://www. facebook.

com/share. php? u=https://www.

hhs. gov/press-room/arpa-h-announces-research-teams-initiative-transform-behavioral-health. html&title=ARPA-H%20announces%20first%20research%20teams%20for%20$139%20million%20initiative%20to%20transform%20behavioral%20health%20and%20bring%20new,%20more%20precise%20and%20effective%20treatments%20to%20Americans "Facebook") * [](https://x.

com/intent/tweet? url=https://www. hhs.

gov/press-room/arpa-h-announces-research-teams-initiative-transform-behavioral-health. html&status=ARPA-H%20announces%20first%20research%20teams%20for%20$139%20million%20initiative%20to%20transform%20behavioral%20health%20and%20bring%20new,%20more%20precise%20and%20effective%20treatments%20to%20Americans+https://www. hhs.

gov/press-room/arpa-h-announces-research-teams-initiative-transform-behavioral-health. html "X") * [](mailto:? subject=ARPA-H%20announces%20first%20research%20teams%20for%20$139%20million%20initiative%20to%20transform%20behavioral%20health%20and%20bring%20new,%20more%20precise%20and%20effective%20treatments%20to%20Americans&body=Check%20out%20this%20site%20https://www.

hhs. gov/press-room/arpa-h-announces-research-teams-initiative-transform-behavioral-health.

html "Email") * The Secretary Kennedy Podcast **Contact: HHS Press Office** Submit a Request for Comment # ARPA-H announces first research teams for $139 million initiative to transform behavioral health and bring new, more precise and effective treatments to Americans _The EVIDENT initiative builds on the Trump Administration’s executive order to accelerate medical treatments for serious mental illness_ The Advanced Research Projects Agency for Health (ARPA-H), an agency within the U.S. Department of Health and Human Services (HHS), is today announcing the first set of research teams for its Evidence-Based Validation & Innovation for Rapid Therapeutics in Behavioral Health (EVIDENT) initiative, which will collectively fund up to $139.

4 million to help spur new, effective therapies for behavioral health. As part of the Trump Administration’s Executive Order to Accelerate Medical Treatments for Serious Mental Illness, EVIDENT will allocate at least $50 million to match state government investments in psychedelic research for populations with serious mental illness.

Over their lifetime, half of all Americans will experience mental or behavioral health disorders, with Veterans facing even higher rates. Since 2000, spending on behavioral health and substance use treatments has skyrocketed from $40. 9 billion a year to more than $140 billion.

Yet promising options have stalled because we continue to lack the tools to objectively know what is working, and for whom. EVIDENT is designed to catalyze a new era in mental and behavioral health treatments by generating FDA-ready clinical endpoints to validate the effectiveness of rapid-acting therapies such as digital interventions, neuromodulation, and neuroplastogens, including the safe use of psychedelics.

“For too long, we’ve dismissed treatments that could genuinely heal people—not because they don’t work, but because medicine has never had the tools, and we’ve lacked the courage to prove it,” **said HHS Secretary Robert F. Kennedy, Jr.**“EVIDENT changes that. ARPA-H is building the measurement science that can finally show what’s happening inside the body when someone is under treatment.

Through this data, we’ll be able to match the right treatment to the right person and know how an individual will respond before it begins. This is about gaining unprecedented insights into the physiology of mental health and unlocking a new class of treatments using hard science that proves what actually works.

” The research teams announced today are just the beginning for EVIDENT, as the initiative will continue to make investments to gather, integrate, and analyze multimodal, longitudinal data from registered clinical trials and real-world care settings on a rolling basis.

These research teams will help build the first generation of scalable, objective measures of behavioral health, enabling providers to move away from trial-and-error approaches of validating treatments and toward precise, personalized, data-driven care.

These measures will also work to accelerate the regulatory approval of effective therapies, reducing the cost of developing interventions for Americans living with conditions such as depression, anxiety, addiction, and post-traumatic stress disorders. “Today, mental health care too often depends on subjective scales, delayed feedback, and trial-and-error,” **said ARPA-H Director Alicia Jackson, Ph. D.

** “Core to ARPA-H's strategy for addressing behavioral health needs is to be able to definitively understand what works for whom, and when. Through EVIDENT, we are investing in objective, predictive measures that will help clinicians know much sooner whether a therapy is working for an individual patient.

These awards are a critical step toward faster relief, fewer failed treatment attempts, and a future where behavioral health care is as measurable and precise as other areas of medicine. ” EVIDENT solicited proposals through four technical areas (TAs) designed to answer four core questions that the field currently cannot reliably answer. * What should we use for objective measurement?

(TA1) * What is happening during treatment? (TA2) * Who will respond to what treatment? (TA3) * What is our shared data foundation?

(TA4) The performer teams are led by: * **Alden Scientific**, in Cambridge, MA, which will provide multi-omics analysis (e.g., proteomics, genomics) to assess physiological changes that may also indicate mental health state and change. * **Attune Neurosciences**, in San Francisco, which will provide data and insights from the use of its low-intensity-focused-ultrasound to deliver neuromodulation therapy for chronic pain and depression.

* **Motif Neurotech**, in Houston, which seeks to accelerate measures of neuromodulation by leading adjunctive data collection. * **NeuroFlow, Inc.**, Philadelphia, which is developing a population-scale framework for evaluating rapid-acting behavioral health interventions against real-world standard care baselines.

* **INVI MindHealth,** in Denver, which is augmenting behavioral health research in neuromodulation and psychedelic therapies with a platform for real-time objective biomarkers as new endpoints for rapidly determining treatment efficacy. * **Diamond Therapeutics**, in Toronto, which, in partnership with **Tactical Mind Research Coalition**, in St.

Petersburg, FL, will contribute data from a phase 2a clinical trial on psilocybin for generalized anxiety disorder. * **Duke University**, in Durham, NC, which will quantify cortisol, estradiol, interleukin 6 (IL 6), and interleukin 1β (IL 1β) from saliva samples to capture stress physiology, endocrine modulation, and inflammatory signaling.

* **Holobiome,**in Boston, which will contribute data through a large-scale clinical trial to identify microbiome-modulating interventions that target the gut-brain axis to decrease stress and anxiety. * **The John Hopkins University School of Medicine**, in Baltimore, which will contribute data from 8 approved clinical trials on psilocybin use across a range of conditions.

* **Ksana Health**, in Eugene, OR, which will integrate continuous wearable device data with electronic health records at unprecedented scale to predict and prevent behavioral health disorders and promote healthy behaviors.

* **The University of Southern California**, in Los Angeles, which will contribute data from a trial on the feasibility and efficacy in healthy adults of psilocybin alone versus with eight weeks of mindfulness training.

* **The University of Wisconsin**, in Madison, which will contribute data from 3 approved psilocybin trials, seeking to dissociate the contributions of conscious psychedelic experience and non-conscious neurobiological mechanisms, as well as examining whether transcutaneous auricular vague nerve stimulation (taVNS) can augment durable outcomes following a single psilocybin session.

* **The Yale Stress Center**, in New Haven, CT, which will contribute data from an interventional clinical trial testing the effects of pregnenolone in individuals with alcohol use disorder. Through EVIDENT, HHS and ARPA-H are building the science that will let promising rapid treatments to finally cross the finish line and become affordable options for Veterans and all Americans who need them.

ARPA-H anticipates future award announcements under the EVIDENT initiative to be made on a rolling basis. To learn more about EVIDENT and stay up to date on awardees and progress, visit the EVIDENT initiative page. Last revised: April 21, 2026 ## Submit a request for comment For media inquiries, please submit a request for comment.

* March 6, 2026 Press Release ## TEFCA™, America’s National Interoperability Network, Reaches Nearly 500 Million Health Records Exchanged as HHS Leverages Technology and AI to Lower Costs and Reduce Burden * February 11, 2026 Press Release ## WTAS: Secretary Kennedy Announces $100 Million Investment in Great American Recovery * February 3, 2026 Press Release Content last reviewed April 21, 2026 [](https://www. facebook.

com/SecKennedy "Visit the Facebook account of Secretary Kennedy") [](https://x. com/SecKennedy "Visit the X account of Secretary Kennedy") [](https://www. instagram.

com/seckennedy/ "Visit the Instagram account of Secretary Kennedy") [](https://truthsocial. com/@seckennedy "Visit the Truth Social account of Secretary Kennedy") [](https://www. linkedin.

com/showcase/secretarykennedy/ "Visit the LinkedIn account of Secretary Kennedy") [](https://www. facebook. com/HHS "Visit the HHS Facebook account") [](https://x.

com/hhsgov "Visit the HHS X account") [](https://www. youtube. com/user/USGOVHHS?

sub_confirmation=1 "Visit the HHS YouTube account") [](https://www. instagram. com/hhsgov/ "Visit the HHS Instagram account") [](https://www.

linkedin. com/company/hhsgov "Visit the HHS LinkedIn account") 200 Independence Avenue, S. W.

Toll Free Call Center: 1-877-696-6775​ * Nondiscrimination Notice